These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 25043685)

  • 21. Cardiovascular Autonomic Neuropathy and Cardiovascular Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
    Pop-Busui R; Braffett BH; Zinman B; Martin C; White NH; Herman WH; Genuth S; Gubitosi-Klug R;
    Diabetes Care; 2017 Jan; 40(1):94-100. PubMed ID: 27803120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk Factors for Longitudinal Resting Heart Rate and Its Associations With Cardiovascular Outcomes in the DCCT/EDIC Study.
    Keshavarzi S; Braffett BH; Pop-Busui R; Orchard TJ; Soliman EZ; Lorenzi GM; Barnie A; Karger AB; Gubitosi-Klug RA; Dagogo-Jack S; Paterson AD;
    Diabetes Care; 2021 May; 44(5):1125-1132. PubMed ID: 33632724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.
    Polak JF; Backlund JY; Cleary PA; Harrington AP; O'Leary DH; Lachin JM; Nathan DM;
    Diabetes; 2011 Feb; 60(2):607-13. PubMed ID: 21270271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes.
    Genuth S
    Endocr Pract; 2006; 12 Suppl 1():34-41. PubMed ID: 16627378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.
    White NH; Sun W; Cleary PA; Danis RP; Davis MD; Hainsworth DP; Hubbard LD; Lachin JM; Nathan DM
    Arch Ophthalmol; 2008 Dec; 126(12):1707-15. PubMed ID: 19064853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Lachin JM; Orchard TJ; Nathan DM;
    Diabetes Care; 2014; 37(1):39-43. PubMed ID: 24356596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview.
    Nathan DM;
    Diabetes Care; 2014; 37(1):9-16. PubMed ID: 24356592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of Foot Ulcer and Lower-Extremity Amputation Among Participants in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
    Boyko EJ; Zelnick LR; Braffett BH; Pop-Busui R; Cowie CC; Lorenzi GM; Gubitosi-Klug R; Zinman B; de Boer IH
    Diabetes Care; 2022 Feb; 45(2):357-364. PubMed ID: 35007329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
    Braffett BH; Gubitosi-Klug RA; Albers JW; Feldman EL; Martin CL; White NH; Orchard TJ; Lopes-Virella M; Lachin JM; Pop-Busui R;
    Diabetes; 2020 May; 69(5):1000-1010. PubMed ID: 32051148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of prior intensive versus conventional therapy and history of glycemia on cardiac function in type 1 diabetes in the DCCT/EDIC.
    Genuth SM; Backlund JY; Bayless M; Bluemke DA; Cleary PA; Crandall J; Lachin JM; Lima JA; Miao C; Turkbey EB;
    Diabetes; 2013 Oct; 62(10):3561-9. PubMed ID: 23520132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study.
    Gubitosi-Klug RA; Braffett BH; White NH; Sherwin RS; Service FJ; Lachin JM; Tamborlane WV;
    Diabetes Care; 2017 Aug; 40(8):1010-1016. PubMed ID: 28550194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Martin CL; Albers JW; Pop-Busui R;
    Diabetes Care; 2014; 37(1):31-8. PubMed ID: 24356595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating vitamin D metabolites and kidney disease in type 1 diabetes.
    de Boer IH; Sachs MC; Cleary PA; Hoofnagle AN; Lachin JM; Molitch ME; Steffes MW; Sun W; Zinman B; Brunzell JD;
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4780-8. PubMed ID: 22990096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of urinary albumin-creatinine ratio and albumin excretion rate in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study.
    Younes N; Cleary PA; Steffes MW; de Boer IH; Molitch ME; Rutledge BN; Lachin JM; Dahms W;
    Clin J Am Soc Nephrol; 2010 Jul; 5(7):1235-42. PubMed ID: 20448066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial.
    Cherney DZI; Zinman B; Inzucchi SE; Koitka-Weber A; Mattheus M; von Eynatten M; Wanner C
    Lancet Diabetes Endocrinol; 2017 Aug; 5(8):610-621. PubMed ID: 28666775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed Gastric Emptying Is Associated With Early and Long-term Hyperglycemia in Type 1 Diabetes Mellitus.
    Bharucha AE; Batey-Schaefer B; Cleary PA; Murray JA; Cowie C; Lorenzi G; Driscoll M; Harth J; Larkin M; Christofi M; Bayless M; Wimmergren N; Herman W; Whitehouse F; Jones K; Kruger D; Martin C; Ziegler G; Zinsmeister AR; Nathan DM;
    Gastroenterology; 2015 Aug; 149(2):330-9. PubMed ID: 25980755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal outcomes in patients with type 1 diabetes and macroalbuminuria.
    de Boer IH; Afkarian M; Rue TC; Cleary PA; Lachin JM; Molitch ME; Steffes MW; Sun W; Zinman B;
    J Am Soc Nephrol; 2014 Oct; 25(10):2342-50. PubMed ID: 24925722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study.
    Albers JW; Herman WH; Pop-Busui R; Feldman EL; Martin CL; Cleary PA; Waberski BH; Lachin JM;
    Diabetes Care; 2010 May; 33(5):1090-6. PubMed ID: 20150297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive performance declines in older adults with type 1 diabetes: results from 32 years of follow-up in the DCCT and EDIC Study.
    Jacobson AM; Ryan CM; Braffett BH; Gubitosi-Klug RA; Lorenzi GM; Luchsinger JA; Trapani VR; Bebu I; Chaytor N; Hitt SM; Farrell K; Lachin JM;
    Lancet Diabetes Endocrinol; 2021 Jul; 9(7):436-445. PubMed ID: 34051936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
    Diabetes; 1999 Feb; 48(2):383-90. PubMed ID: 10334318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.